133 related articles for article (PubMed ID: 35018242)
1.
Futamura M; Tokumaru Y; Takabe K; Arakawa H; Asano Y; Mori R; Mase J; Nakakami A; Yoshida K
Am J Cancer Res; 2021; 11(12):6060-6073. PubMed ID: 35018242
[TBL] [Abstract][Full Text] [Related]
2. Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
Gaowa S; Futamura M; Tsuneki M; Kamino H; Tajima JY; Mori R; Arakawa H; Yoshida K
Cancer Sci; 2018 Dec; 109(12):3910-3920. PubMed ID: 30290054
[TBL] [Abstract][Full Text] [Related]
3. p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers.
Sano H; Futamura M; Gaowa S; Kamino H; Nakamura Y; Yamaguchi K; Tanaka Y; Yasufuku I; Nakakami A; Arakawa H; Yoshida K
Biochem Biophys Res Commun; 2020 Aug; 529(3):582-589. PubMed ID: 32736677
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Mieap-regulated mitochondrial quality control as a new function of tumor suppressor p53.
Nakamura Y; Arakawa H
Cancer Sci; 2017 May; 108(5):809-817. PubMed ID: 28222492
[TBL] [Abstract][Full Text] [Related]
5. Mieap, a p53-inducible protein, controls mitochondrial quality by repairing or eliminating unhealthy mitochondria.
Kitamura N; Nakamura Y; Miyamoto Y; Miyamoto T; Kabu K; Yoshida M; Futamura M; Ichinose S; Arakawa H
PLoS One; 2011 Jan; 6(1):e16060. PubMed ID: 21264228
[TBL] [Abstract][Full Text] [Related]
6. High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.
Tokumaru Y; Katsuta E; Oshi M; Sporn JC; Yan L; Le L; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357442
[TBL] [Abstract][Full Text] [Related]
7. Mieap-regulated mitochondrial quality control is frequently inactivated in human colorectal cancer.
Kamino H; Nakamura Y; Tsuneki M; Sano H; Miyamoto Y; Kitamura N; Futamura M; Kanai Y; Taniguchi H; Shida D; Kanemitsu Y; Moriya Y; Yoshida K; Arakawa H
Oncogenesis; 2016 Jan; 4(1):e181. PubMed ID: 26727575
[TBL] [Abstract][Full Text] [Related]
8. CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.
Sato T; Oshi M; Huang JL; Chida K; Roy AM; Endo I; Takabe K
Res Sq; 2024 Mar; ():. PubMed ID: 38585981
[TBL] [Abstract][Full Text] [Related]
9. Mieap forms membrane-less organelles involved in cardiolipin metabolism.
Ikari N; Honjo K; Sagami Y; Nakamura Y; Arakawa H
iScience; 2024 Feb; 27(2):108916. PubMed ID: 38322995
[TBL] [Abstract][Full Text] [Related]
10. High miR-99b expression is associated with cell proliferation and worse patient outcomes in breast cancer.
Oshi M; Tokumaru Y; Benesch MG; Sugito N; Wu R; Yan L; Yamada A; Chishima T; Ishikawa T; Endo I; Takabe K
Am J Cancer Res; 2022; 12(10):4840-4852. PubMed ID: 36381329
[TBL] [Abstract][Full Text] [Related]
11. Mieap suppresses murine intestinal tumor via its mitochondrial quality control.
Tsuneki M; Nakamura Y; Kinjo T; Nakanishi R; Arakawa H
Sci Rep; 2015 Jul; 5():12472. PubMed ID: 26216032
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
[TBL] [Abstract][Full Text] [Related]
13. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098
[TBL] [Abstract][Full Text] [Related]
14. BNIP3 and NIX mediate Mieap-induced accumulation of lysosomal proteins within mitochondria.
Nakamura Y; Kitamura N; Shinogi D; Yoshida M; Goda O; Murai R; Kamino H; Arakawa H
PLoS One; 2012; 7(1):e30767. PubMed ID: 22292033
[TBL] [Abstract][Full Text] [Related]
15. Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors.
Mussazhanova Z; Shimamura M; Kurashige T; Ito M; Nakashima M; Nagayama Y
Cancer Sci; 2020 Aug; 111(8):2814-2823. PubMed ID: 32458504
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
[TBL] [Abstract][Full Text] [Related]
17. Possible existence of lysosome-like organella within mitochondria and its role in mitochondrial quality control.
Miyamoto Y; Kitamura N; Nakamura Y; Futamura M; Miyamoto T; Yoshida M; Ono M; Ichinose S; Arakawa H
PLoS One; 2011 Jan; 6(1):e16054. PubMed ID: 21264221
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of
Li C; Zhang G; Wang Y; Chen B; Li K; Cao L; Ren C; Wen L; Jia M; Mok H; Lai J; Xiao W; Li X; Liao N
Oncol Lett; 2022 Feb; 23(2):68. PubMed ID: 35069877
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Role of
Hwang KT; Kim BH; Oh S; Park SY; Jung J; Kim J; Choi IS; Jeon SY; Kim WY
J Breast Cancer; 2019 Dec; 22(4):548-561. PubMed ID: 31897329
[TBL] [Abstract][Full Text] [Related]
20. The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
Talia M; De Francesco EM; Rigiracciolo DC; Muoio MG; Muglia L; Belfiore A; Maggiolini M; Sims AH; Lappano R
Cells; 2020 Mar; 9(3):. PubMed ID: 32143514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
